VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,320,906 | -73.4% | 119,323 | -62.4% | 0.00% | -83.3% |
| Q2 2023 | $4,959,444 | +86497.6% | 317,506 | -3.9% | 0.01% | -33.3% |
| Q1 2023 | $5,727 | +273.6% | 330,463 | +102.7% | 0.01% | +200.0% |
| Q4 2022 | $1,533 | -98.4% | 163,043 | +386.7% | 0.00% | – |
| Q2 2022 | $93,000 | +31.0% | 33,500 | +43.8% | 0.00% | – |
| Q1 2022 | $71,000 | -73.0% | 23,300 | -59.0% | 0.00% | – |
| Q4 2021 | $263,000 | +15.4% | 56,850 | +54.1% | 0.00% | – |
| Q2 2021 | $228,000 | -28.8% | 36,900 | -30.2% | 0.00% | – |
| Q1 2021 | $320,000 | -36.0% | 52,900 | -37.2% | 0.00% | -100.0% |
| Q3 2020 | $500,000 | -35.4% | 84,300 | -20.9% | 0.00% | -50.0% |
| Q2 2020 | $774,000 | +19.1% | 106,600 | -22.3% | 0.00% | +100.0% |
| Q1 2020 | $650,000 | -38.0% | 137,215 | -9.2% | 0.00% | -66.7% |
| Q3 2019 | $1,049,000 | -43.3% | 151,100 | -38.1% | 0.00% | -40.0% |
| Q4 2018 | $1,849,000 | -68.1% | 244,274 | -26.6% | 0.01% | -61.5% |
| Q3 2018 | $5,798,000 | – | 332,810 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |